Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ju Dong Yang

Showing results (11-20 of 292) with videos related to

Pageof 30
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 8, 2017
ReplyJu Dong Yang, Michael D Leise
Nature Reviews. Gastroenterology & Hepatology|July 15, 2010
Hepatocellular carcinoma: A global viewJu Dong Yang, Lewis R Roberts
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 25, 2011
Surveillance for hepatocellular carcinoma in patients with cirrhosisJu Dong Yang, W Ray Kim
Clinical and Molecular Hepatology|May 14, 2024
Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: A gateway to personalized medicine: Editorial on "Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma"Joseph C Ahn, Ju Dong Yang
BMJ (Clinical Research Ed.)|October 27, 2020
New advances in the diagnosis and management of hepatocellular carcinomaJu Dong Yang, Julie K Heimbach
Hepatology (Baltimore, Md.)|April 27, 2018
Does cirrhosis associated with well controlled viral hepatitis confer a risk for extrahepatic cancer?Ju Dong Yang, Gregory J Gores
Current Hepatology Reports|August 22, 2022
Management of combined hepatocellular carcinoma-cholangiocarcinomaJu Dong Yang, Lewis R Roberts
Infectious Disease Clinics of North America|October 13, 2010
Epidemiology and management of hepatocellular carcinomaJu Dong Yang, Lewis R Roberts
Translational Gastroenterology and Hepatology|November 6, 2024
Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver diseaseJeff Liang, Naomy Kim, Ju Dong Yang
Alimentary Pharmacology & Therapeutics|March 7, 2026
Editorial: Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Prior to Liver Transplantation-Current Evidence and Future DirectionsMohammad Saeid Rezaee-Zavareh, Ju Dong Yang
Pageof 30

Showing results (11-20 of 292) with videos related to

Sort By:
Pageof 30
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 8, 2017
ReplyJu Dong Yang, Michael D Leise
Nature Reviews. Gastroenterology & Hepatology|July 15, 2010
Hepatocellular carcinoma: A global viewJu Dong Yang, Lewis R Roberts
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 25, 2011
Surveillance for hepatocellular carcinoma in patients with cirrhosisJu Dong Yang, W Ray Kim
Clinical and Molecular Hepatology|May 14, 2024
Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: A gateway to personalized medicine: Editorial on "Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma"Joseph C Ahn, Ju Dong Yang
BMJ (Clinical Research Ed.)|October 27, 2020
New advances in the diagnosis and management of hepatocellular carcinomaJu Dong Yang, Julie K Heimbach
Hepatology (Baltimore, Md.)|April 27, 2018
Does cirrhosis associated with well controlled viral hepatitis confer a risk for extrahepatic cancer?Ju Dong Yang, Gregory J Gores
Current Hepatology Reports|August 22, 2022
Management of combined hepatocellular carcinoma-cholangiocarcinomaJu Dong Yang, Lewis R Roberts
Infectious Disease Clinics of North America|October 13, 2010
Epidemiology and management of hepatocellular carcinomaJu Dong Yang, Lewis R Roberts
Translational Gastroenterology and Hepatology|November 6, 2024
Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver diseaseJeff Liang, Naomy Kim, Ju Dong Yang
Alimentary Pharmacology & Therapeutics|March 7, 2026
Editorial: Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Prior to Liver Transplantation-Current Evidence and Future DirectionsMohammad Saeid Rezaee-Zavareh, Ju Dong Yang
Pageof 30